(2<em>S</em>,3<em>R</em>,6<em>R</em>)-2-[(<em>R</em>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<em>H</em>-pyran-3-ol
(2<i>S</i>,3<i>R</i>,6<i>R</i>)-2-[(<i>R</i>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<i>H</i>-pyran-3-ol was isolated in 18% after treating the glucose derived (5<i>R</i>,6<i>S</i>,7<i>R</i>)-5...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Molbank |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-8599/2020/2/M1140 |
_version_ | 1827715632042344448 |
---|---|
author | Jack Bennett Paul V. Murphy |
author_facet | Jack Bennett Paul V. Murphy |
author_sort | Jack Bennett |
collection | DOAJ |
description | (2<i>S</i>,3<i>R</i>,6<i>R</i>)-2-[(<i>R</i>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<i>H</i>-pyran-3-ol was isolated in 18% after treating the glucose derived (5<i>R</i>,6<i>S</i>,7<i>R</i>)-5,6,7-tris[(triethylsilyl)oxy]nona-1,8-dien-4-one with (1<i>S</i>)-(+)-10-camphorsulfonic acid (CSA). The one-pot formation of the title compound involved triethylsilyl (TES) removal, alkene isomerization, intramolecular conjugate addition and ketal formation. The compound was characterized by <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy, ESI mass spectrometry and IR spectroscopy. NMR spectroscopy was used to establish the product structure, including the conformation of its tetrahydropyran ring. |
first_indexed | 2024-03-10T19:23:38Z |
format | Article |
id | doaj.art-448bbba3ef864b979de0a65539ba1623 |
institution | Directory Open Access Journal |
issn | 1422-8599 |
language | English |
last_indexed | 2024-03-10T19:23:38Z |
publishDate | 2020-06-01 |
publisher | MDPI AG |
record_format | Article |
series | Molbank |
spelling | doaj.art-448bbba3ef864b979de0a65539ba16232023-11-20T02:46:11ZengMDPI AGMolbank1422-85992020-06-0120202M114010.3390/M1140(2<em>S</em>,3<em>R</em>,6<em>R</em>)-2-[(<em>R</em>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<em>H</em>-pyran-3-olJack Bennett0Paul V. Murphy1School of Chemistry, National University of Ireland, H91 TK33 Galway, IrelandSchool of Chemistry, National University of Ireland, H91 TK33 Galway, Ireland(2<i>S</i>,3<i>R</i>,6<i>R</i>)-2-[(<i>R</i>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<i>H</i>-pyran-3-ol was isolated in 18% after treating the glucose derived (5<i>R</i>,6<i>S</i>,7<i>R</i>)-5,6,7-tris[(triethylsilyl)oxy]nona-1,8-dien-4-one with (1<i>S</i>)-(+)-10-camphorsulfonic acid (CSA). The one-pot formation of the title compound involved triethylsilyl (TES) removal, alkene isomerization, intramolecular conjugate addition and ketal formation. The compound was characterized by <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy, ESI mass spectrometry and IR spectroscopy. NMR spectroscopy was used to establish the product structure, including the conformation of its tetrahydropyran ring.https://www.mdpi.com/1422-8599/2020/2/M1140glucosetetrahydropyrandeprotectioncyclisationfunctionalized scaffold |
spellingShingle | Jack Bennett Paul V. Murphy (2<em>S</em>,3<em>R</em>,6<em>R</em>)-2-[(<em>R</em>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<em>H</em>-pyran-3-ol Molbank glucose tetrahydropyran deprotection cyclisation functionalized scaffold |
title | (2<em>S</em>,3<em>R</em>,6<em>R</em>)-2-[(<em>R</em>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<em>H</em>-pyran-3-ol |
title_full | (2<em>S</em>,3<em>R</em>,6<em>R</em>)-2-[(<em>R</em>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<em>H</em>-pyran-3-ol |
title_fullStr | (2<em>S</em>,3<em>R</em>,6<em>R</em>)-2-[(<em>R</em>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<em>H</em>-pyran-3-ol |
title_full_unstemmed | (2<em>S</em>,3<em>R</em>,6<em>R</em>)-2-[(<em>R</em>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<em>H</em>-pyran-3-ol |
title_short | (2<em>S</em>,3<em>R</em>,6<em>R</em>)-2-[(<em>R</em>)-1-Hydroxyallyl]-4,4-dimethoxy-6-methyltetrahydro-2<em>H</em>-pyran-3-ol |
title_sort | 2 em s em 3 em r em 6 em r em 2 em r em 1 hydroxyallyl 4 4 dimethoxy 6 methyltetrahydro 2 em h em pyran 3 ol |
topic | glucose tetrahydropyran deprotection cyclisation functionalized scaffold |
url | https://www.mdpi.com/1422-8599/2020/2/M1140 |
work_keys_str_mv | AT jackbennett 2emsem3emrem6emrem2emrem1hydroxyallyl44dimethoxy6methyltetrahydro2emhempyran3ol AT paulvmurphy 2emsem3emrem6emrem2emrem1hydroxyallyl44dimethoxy6methyltetrahydro2emhempyran3ol |